S. B. Hanauer

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

William J. Sandborn, S. B. Hanauer, P. Rutgeerts et al. · Gut · 2007 · 1K citations · Full text

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial

William J. Sandborn, S. B. Hanauer, Seymour Katz et al. · Gastroenterology · 2001 · 905 citations · Full text

Functional Gastrointestinal Disorder, Gastroenterology, Clinical Trials +5

Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial

Eli D. Ehrenpreis, Sunanda V. Kane, Lawrence B. Cohen et al. · Gastroenterology · 1999 · 330 citations

Open-label Trial, Thalidomide Therapy, Gastroenterology +5

An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial

William J. Sandborn, Brian G. Feagan, S. B. Hanauer et al. · Gastroenterology · 2001 · 252 citations · Full text

Inflammation, Mucosal Immunology, Medicine +8

Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study

Stefan Schreiber, Ian C. Lawrance, Ole Østergaard Thomsen et al. · Alimentary Pharmacology & Therapeutics · 2010 · 160 citations · Full text